CAMBRIDGE, Mass., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and genetically defined diseases, today announced that the company is scheduled to present at the following March investor conferences:

More:
Agios to Present at March Investor Conferences

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh